Article
Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis
Fecha
2015Registro en:
282, , 39-44
01655728
Autor
Serrano-Pertierra E.
Blanco-Gelaz M.A.
Oliva-Nacarino P.
Martínez-Camblor P.
Villafani J.
López-Larrea C.
Cernuda-Morollón E.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Optimizing outcomes in multiple sclerosis: Consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America
Autor desconocido (SAGE Publications, 2011)Objective: The prevalence of multiple sclerosis (MS) in Latin America varies across different studies but an intermediate risk and increased frequency of the disease have been reported in recent years. The circumstances ... -
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
Autor desconocido (BioMed Central, 2014)Background: Human T-cell lymphotropic virus (HTLV-1) is the causative agent of the incapacitating, neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Currently, there are no ... -
Clinical features of 314 patients with relapsing-remitting multiple sclerosis [Esclerosis múltiple recurrente remitente en el sector público de salud de chile. descripción clínica de 314 pacientes]
Nogales-Gaete J.; Aracena R.; Cepeda-Zumaeta S.; Eloiza C.; Agurto P.; Díaz V.; Labbé S.; Martínez S.; Flores J.; Araya C. (Sociedad Medica de Santiago, 2014)